"Buserelin"^^ . "Buserelin"^^ . "C60H86N16O13"^^ . "EtilamideBRNCI" . "725176"^^ . "6-[O-(1,1-Dimethylethyl)-D-serine]-9-(N-ethyl-L-prolinamide)-10-deglycinamide-luteinizing Hormone-releasing Factor (Pig)PTDCP01294" . "An anticancer drug that belongs to the family of drugs called gonadotropin-releasing hormones. In prostate cancer therapy, buserelin blocks the production of testosterone in the testicles.NCI-GLOSS" . "S74-6766CNNCI" . . . . "39170"^^ . . "ICI 123215CNNCI" . "Prostate cancer"^^ . "39170"^^ . "6-[O-(1,1-Dimethylethyl)-D-serine]-9-(N-ethyl-L-prolinamide)-10-deglycinamide Luteinizing Hormone-Releasing Factor (Pig)SNNCI" . "HOE 766CNNCI" . "buserelinPTNCI-GLOSSCDR0000045180" . "A synthetic analog of gonadotropin-releasing hormone (GnRH). Buserelin binds to and activates pituitary gonadotropin releasing hormone (GnRH) receptors. Prolonged administration of buserelin results in sustained inhibition of gonadotropin production, suppression of testicular and ovarian steroidogenesis, and reduced levels of circulating gonadotropin and gonadal steroids. Buserelin is more potent that GnRH. (NCI04)NCI" . . "BUSERELINPTFDAPXW8U3YXDV" . "PXW8U3YXDV"^^ . "Breast cancer; Contraception, female; Endometriosis; Infertility; in vitro fertilization; Polycystic ovary syndrome; Prostate cancer; Uterine leiomyoma"^^ . "Pharmacologic Substance"^^ . "Buserelin"^^ . "57982-77-1"^^ . "C0006456"^^ . "FDA"^^ . "BuserelinPTNCI" . "BuserelineSYNCI" . "C320"^^ . "Amino Acid, Peptide, or Protein"^^ . . "BSRLABNCI" .